Deltec Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.9M Sell
8,550
-250
-3% -$295K 1.54% 16
2026
Q2
$10.6M Buy
8,800
+50
+0.6% +$51.1K 1.56% 16
2026
Q1
$8.05M Hold
8,750
– – 1.48% 18
2025
Q4
$9.4M Hold
8,750
– – 1.56% 13
2025
Q3
$6.68M Buy
8,750
+2,000
+30% +$1.49M 1.1% 22
2025
Q2
$5.26M Buy
6,750
+1,000
+17% +$777K 0.94% 25
2025
Q1
$4.75M Hold
5,750
– – 1.02% 27
2024
Q4
$4.44M Sell
5,750
-300
-5% -$248K 0.88% 29
2024
Q3
$5.36M Hold
6,050
– – 1.06% 26
2024
Q2
$5.48M Sell
6,050
-600
-9% -$480K 1.05% 27
2024
Q1
$5.17M Hold
6,650
– – 1.02% 26
2023
Q4
$3.88M Sell
6,650
-1,050
-14% -$613K 0.87% 28
2023
Q3
$4.14M Sell
7,700
-400
-5% -$206K 0.94% 27
2023
Q2
$3.8M Hold
8,100
– – 0.83% 33
2023
Q1
$2.78M Buy
+8,100
New +$2.73M 0.69% 39

Other funds holding LLY

Deltec Asset Management's LLY Position: Q3 2026 in Review

Deltec Asset Management reduced its Eli Lilly (LLY) stake by 2.8% in Q3 2026, selling an estimated $295K and leaving 8,550 shares worth $9.9M. The position accounts for 1.54% of the portfolio, ranked #16.

Deltec Asset Management first reported a position in LLY in Q1 2023 and has held it in 15 quarters since. The position peaked at $10.6M in Q2 2026. 3,293 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Deltec Asset Management held 8,550 shares of Eli Lilly worth $9.9M as of Q3 2026.
  • Deltec Asset Management sold 250 Eli Lilly shares in Q3 2026, an estimated $295K.
  • Eli Lilly made up 1.54% of Deltec Asset Management's portfolio in Q3 2026, its #16 holding.
  • Deltec Asset Management first reported a position in Eli Lilly in Q1 2023 and has held it in 15 quarters since.
  • Deltec Asset Management's Eli Lilly position peaked at $10.6M in Q2 2026.
  • 3,293 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Deltec Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.